Ann: ONJCRI Evaluates Monepantel Anti-Cancer Mechanism, page-81

Couldn’t agree more. What a rollercoaster, seems sh’s have become pretty sceptical about the journey thus far, re lack of transparency, timelines, updates, ect. Now there’s a flurry and of positivity and we’re going backward, or hovering, go figure!
Myself would of added more credibility if they gave us some reasoning around the Elanco option not being taken up, but the evidence and results so far don’t paint a picture of a drug that misses the mark.
I’m going glass half full also, had averaged up accumulating into the low 20’s, and now I’m averaging down, believing I’m only adding to my family’s future. Believe others are quietly picking up a bargain at the expense of the weak and weary also! Atb!